Atara BiotherapeuticsATRA
13F holders, Q2 2024 (June 30)5holders −77
1new positions
79sold out
$8.30avg. 13F price*
At the end of Q2 2024, 5 institutions reported holding Atara Biotherapeutics Inc. (ATRA) in their 13F filings, down 77 from Q1 2024. 1 opened new positions and 79 sold out. The largest holders were Boxer Capital, LLC ($1.4M), Lake Street Advisors Group, LLC ($94K) and Cwm, LLC ($5K).
- Company
- Atara Biotherapeutics Inc.
- CUSIP
- 046513107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $344 |
| Exits | 79 | $55.0M |
All 13F filers, Q1 2024 → Q2 2024: 35 shares bought and 83,101,602 shares sold, net −83,101,567 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Boxer Capital, LLC | 0.07% | Reduce -96.0% | 166,000 | $1.4M |
| Lake Street Advisors Group, LLC | 0.00% | No change | 11,000 | $94K |
| Cwm, LLC | 0.00% | Reduce -97.3% | 542 | $5K |
| IFP Advisors, Inc | 0.00% | No change | 4,500 | $2K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 35 | $344 |
"% of holder's portfolio" is ATRA's weight in each manager's 13F, not the share of Atara Biotherapeutics Inc. the manager owns.